Jump to content Jump to main menu Jump to sub menu

Latest News

10 September 2010 - QED – Biotech’s Favourite CRO

QED today announced its vision and strategy for 2011.  Given QED’s continued success and growth predominantly within the Biotech sector and re-affirming our positioning as a partner of choice in this area, the company has tailored its service provision appropriately.  Thomas Ogorka, QED CEO, commented “QED is acutely aware that although the Biotech industry is highly innovative and is constantly evolving perhaps the traditional CRO and service provider industry that support it have not developed at the same rate.   With our commitment to addressing the needs of Biotech firms specifically we are confident that our Sponsors projects will receive the priority and focus they deserve from QED.”  To learn more about how QED effectively works with Biotech sponsors, please click here.